|Bid||1,731.00 x 34700|
|Ask||1,747.00 x 29800|
|Day's Range||1,724.00 - 1,746.00|
|52 Week Range||1,225.00 - 1,970.00|
|PE Ratio (TTM)||113.86|
|Earnings Date||Sep 4, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||1,730.14|
These two shares may offer higher growth rates than expected.
Royston Wild looks at two stocks with hot earnings prospects.
Categories: Europe Value Analsysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Dechra Pharmaceuticals Plc a score of 50. Our analysis is based on comparing Dechra Pharmaceuticals Plc with the following peers – Alliance Pharma plc, Hikma Pharmaceuticals Plc, Vectura Group plc, ECO Animal Health Group plc, BTG plc, GlaxoSmithKline plc, Sinclair Pharma plc, Allergy Therapeutics plc, CVS Group ... Read more (Read more...)